— Know what they know.
Not Investment Advice

GKOS NYSE

Glaukos Corporation
1W: -2.1% 1M: +14.4% 3M: +15.7% YTD: +25.6% 1Y: +42.7% 3Y: +132.2% 5Y: +86.1%
$120.23
-18.80 (-13.52%)
After Hours: $122.17 (+1.94, +1.62%)
Weekly Expected Move ±12.1%
$109 $127 $144 $161 $179
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 62 · $7.1B mcap · 56M float · 1.32% daily turnover · Short 57% of daily vol

Cash Flow Trends

Operating Cash Flow
-$46M +24.4% ▲
Capital Expenditures
$8M -21.7% ▼
5Y CAGR: +2.0%
Free Cash Flow
-$54M +20.1% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$111M -246.1% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$50M-$99M-$135M-$146M-$134M
Depreciation & Amort.$34M$36M$38M$40M$38M
Stock-Based Comp.$0$0$0$0$63M
Change in Working Capital$4M-$13M-$10M-$39M-$32M
Other Non-Cash Items$37M$44M$49M$85M$24M
Operating Cash Flow$25M-$33M-$58M-$61M-$46M
— Investing Activities —
Capital Expenditures-$48M-$30M-$20M-$6M-$8M
Acquisitions (Net)$3K$151K$0$38K-$12M
Investment Purchases-$215M-$59M-$266M-$190M-$232M
Investment Sales$207M$135M$303M$247M$197M
Other Investing-$2M-$1M-$3M-$3M-$22M
Investing Cash Flow-$58M$45M$14M$48M-$78M
— Financing Activities —
Net Debt Issuance-$659K-$527K-$711K$51M$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$9M-$2M-$3M-$7M$12M
Financing Cash Flow$39M$6M$15M$92M$12M
Net Change in Cash$4M$19M-$26M$76M-$111M
Cash End of Period$101M$120M$93M$170M$63M
Free Cash Flow-$23M-$63M-$78M-$68M-$54M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms